Each year, MJBizCon brings together thousands of cannabis professionals from across the globe to unite in Las Vegas. While the show covers the B2B cannabis industry seed–to–sale including cultivation, manufacturing retail, and business services, there is one growing theme. From innovative medical applications to cross-border collaborations, the medical sector is steadily–but powerfully–shaping the global cannabis economy.  

Science at the Forefront: Medical-Focused Sessions  

MJBizCon is not just a North American conference and trade show. With a significant percentage of international attendees, collaboration and information sharing is more important than ever. This year, MJBizCon’s Science Symposium Pre-Show Forum provides an inside look at the medical industry by spotlighting the following topics:  

• From Clinic to Cannabinoid: Real-World Evidence and Best Practices in Medical Cannabis Treatment 

• Cannabinoids for Mental Health: Evidence, Protocols, and Practice 

• Cannabis & Pain Management: Exploring Clinical Alternatives to Opioids 

• From Cradle to Cane: Advancing Pediatric & Geriatric Cannabis Care 

• Personalized Cannabis Medicine: Tailoring Treatment Through Genetics, Biomarkers, and AI 

• Women’s Health & Cannabis: Exploring Therapeutic Potential for Menopause, Endometriosis, and Hormonal Balance 
• Cannabis & Sleep Disorders: A Scientific Review of Cannabinoids and Sleep Health 

Bridging Borders: Regulatory Alignment Across Countries and States 

Another theme MJBizCon is focusing on this year is regulatory alignment. With the goal of creating frameworks on navigating compliance across global markets, MJBizCon hopes to help clarify the grey area surrounding policy and process. MJBizCon is not just about business deals but shaping the future of the industry. By enhancing international and domestic collaboration, we hope to facilitate change that will support cannabis business communities for years to come.  

Here are some of the Sessions MJBizCon is hosting this year in Las Vegas:  

Regulatory Roundup (Domestic) 

• Midwest Momentum: Navigating the Cannabis Landscape in Ohio & Michigan 

• Mid-Atlantic Expectations: Cannabis Industry Developments in Maryland, Virginia & Washington, D.C. 
• Land of 10,000 Lakes and Legalization: Minnesota’s Cannabis Industry in Transition 

Regulatory Roundup (International) 

• Global Cannabis Outlook: Trends, Policy Shifts & Market Opportunities Around the World 

• Europe on the Move: Regulatory Updates, Market Growth & Investment Opportunities Across the EU 

• North American Cannabis Market Perspectives: Policy Shifts, Market Moves & Cross-Border Trends 

“With more new cannabis markets on the horizon, the industry will add upward of $200 billion in additional spending to the U.S. economy by 2030. Direct medical and recreational marijuana sales are estimated to reach $35.3 billion in 2025 with an additional $88.3 billion added to the broader economy”. – MJBizDaily

As more countries create a medical cannabis legalization framework, it is more important than ever to enhance our global outlook, fostering improvements to support patients, and facilitating progress within the industry. By combining science, and regulation, we hope that attendees can gain insights to support strategic initiatives related to global cannabis medical markets. Interested in attending these Sessions and more? Register for MJBizCon. 

Exhibiting at MJBizCon also provides the opportunity to showcase your product, develop strong relationships with other exhibitors, and connect with attendees on a deeper level. International Exhibitors such as CCell and Hefestus already secured their spot! Be sure to join them before all the spots are filled!